PrimeVigilance reposted this
Day two at DIA in Basel, PrimeVigilance BD team here to engage and discuss your PV/MI initiatives for 2025!@ Rada Gantly Daniel Kelly
PrimeVigilance, an Ergomed Group company, was established in 2008 by Dr. Miroslav Reljanovic together with co-founder Dr. Elliot Brown. PrimeVigilance offers holistic, top quality, cost-effective, innovative clinical safety and PV services for pharmaceutical, biotechnology and medical device companies. Our leaders have an unrivalled reputation in the sector with a network of SMEs across the world. These include former senior regulators and consultants with expansive industry experience. We augment our domain expertise by integrating medical and scientific knowledge with regulatory science in clinical settings and in everyday practice. We identify previously unrecognized adverse effects or changes in their patterns to ascertain what action is necessary to optimize safe and effective use of medicines and medical devices. Our adaptable business models and integrative project management coupled with our flexibility as a partner, consistently fulfill our clients’ business requirements and safeguard their assets. We bring together a team of 1000 professionals, located in 3 continents, whose skills, values and ingenuity make us unique in clinical safety and pharmacovigilance. We connect our clients to the right safety services and solutions. We specialize in helping emerging and established pharma and biotech companies comply with regulations, from developing PV systems right through to full management of safety operations. We are a partner who shares your commitment to patient safety and that purpose binds us all.
External link for PrimeVigilance
PrimeVigilance reposted this
Day two at DIA in Basel, PrimeVigilance BD team here to engage and discuss your PV/MI initiatives for 2025!@ Rada Gantly Daniel Kelly
📸 Snapshots from #DIAEurope2025 in Basel! We’re still here at Booth D5 today and tomorrow—don’t miss the chance to connect with our PrimeVigilance experts at this leading event! 🚀 Let’s talk about your drug safety strategy—visit us at Booth D5! #DIAEurope2025 #Pharmacovigilance #DrugSafety
Expanding into Biosimilars? Ensure Safety & Compliance 💡 Biosimilars require specialized pharmacovigilance—tailored workflows, rigorous safety monitoring, and expert regulatory navigation. PrimeVigilance helps pharma and biotech companies seamlessly integrate biosimilars while ensuring global compliance. Download our case study to see how our expert-driven PV solutions support safe, efficient biosimilar expansion: https://bit.ly/3DB7GWu
📸 Live from the American Drug Safety Summit 2025 - Stop by Booth #2 today in Boston to meet the PrimeVigilance team! Take a sneak peak into Nina Patel Lahanis's (Vice President, Safety Data Management) presentation titled "Case Study: Optimizing Quality of Deliverables with PV Vendors"! Connect with us at Booth #2 to explore how PrimeVigilance can enhance your pharmacovigilance operations. #Pharmacovigilance #RiskManagement #PrimeVigilance
We’re excited to connect at DIA Europe 2025 in Basel, Switzerland! Join PrimeVigilance at Booth D5 next week to explore how our pharmacovigilance & risk management solutions can support your drug safety strategy. Meet our experts: ✅ Alessandro Di Ranno – VP, Business Development ✅ Olivija Sileike – Director, Business Development ✅ Daniel Kelly – Director, Business Development ✅ Rada Gantly – Director, Business Development Let’s discuss your safety strategy! Schedule a meeting or drop by #BoothD5: https://lnkd.in/d-GjWmNG #DIAEurope2025 #Pharmacovigilance #DrugSafety #PrimeVigilance
Navigating the complexities of pharmacovigilance and patient safety? PrimeVigilance provides comprehensive, end-to-end PV solutions—from clinical development to post-marketing—to ensure regulatory compliance, mitigate risk, and safeguard patients worldwide. ✅ Proven expertise 🌍 Global reach 🔗 Seamless integration Partner with an industry leader committed to excellence in #drugsafety. Let’s talk: https://lnkd.in/eUnpCQd
💡 Visit PrimeVigilance Booth #2 at the American Drug Safety Summit 2025 this week! As a global leader in #pharmacovigilance and #riskmanagement, PrimeVigilance empowers biotech and pharmaceutical companies with innovative, scalable, and regulatory-compliant solutions to enhance drug safety and patient well-being. Our team will be on-site, ready to discuss how PrimeVigilance can support your pharmacovigilance and risk management strategies: - Nina Lahanis, VP of Safety Data Management - Chris Agresti, Director of Business Development - Jen Fitzpatrick, Manager of Business Development - Jimmy King, Sales Development Account Manager 💬 Schedule a meeting here: https://lnkd.in/dpJxmKhQ #PrimeVigilance #DrugSafetySummit #Pharmacovigilance #RiskManagement #DrugSafety #LifeSciences #BostonEvents
PrimeVigilance reposted this
Great F2F meeting today with the PrimeVigilance North American Project Management team! Team building and engaging discussions made it a productive session. Feeling grateful for such a wonderful team! 💙🧡 #Teamwork #Productivity #PrimeVigilance
The PrimeVigilance team is gearing up for DIA Europe 2025, where we’ll be sharing insights on cutting-edge pharmacovigilance and risk management solutions designed for the evolving needs of biotech and pharmaceutical companies. 📍 Booth D5 | March 18-20, 2025 | Basel, Switzerland Book a meeting or stop by Booth #D5 to explore how PrimeVigilance can support your drug safety strategy: https://lnkd.in/d-GjWmNG #DIAEurope2025 #Pharmacovigilance #DrugSafety #PrimeVigilance
Join PrimeVigilance expert speaker, Nina Patel Lahanis (Vice President, Safety Data Management) at the American Drug Safety Summit 2025! 📌 "Case Study: Optimizing Quality of Deliverables with PV Vendors" 📅 March 13, 2025 | 09:30 AM Dive deep into a compelling case study on optimizing pharmacovigilance vendor partnerships to enhance regulatory compliance, operational efficiency, and patient safety outcomes. Connect with us at Booth #2 to explore how PrimeVigilance can enhance your pharmacovigilance operations. Setup a meeting now: https://lnkd.in/dpJxmKhQ #PrimeVigilance #AmericanDrugSafetySummit #Pharmacovigilance #DrugSafety